Last reviewed · How we verify
NCT05255224: PARADISE
PARADISE: Predicting AF After Cardiac Surgery
trial testing Not applicable as observational study in Atrial Fibrillation New Onset in 13,684 participants. Status unknown.
31 May 2025
Quick facts
| Lead sponsor | University of Oxford |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 13,684 |
| Start date | 1 October 2021 |
| Primary completion | 31 May 2025 |
| Estimated completion | 31 May 2025 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Not applicable as observational study
Conditions studied
- Atrial Fibrillation New Onset — all drugs for Atrial Fibrillation New Onset →
Sponsor
University of Oxford
Who can join
18 and older, any sex, with Atrial Fibrillation New Onset. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The PARADISE study aims to develop and validate prediction tools to identify patients at risk of Atrial Fibrillation (AF) after cardiac surgery.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A Systematic Review of Ongoing Registered Research Studies on Post-Operative Atrial Fibrillation after Cardiac Surgery.
Quan I, Belley-Côté EP, Spence J, Wang A, et al · · 2024 · cited 3× · PMID 39201089 · DOI 10.3390/jcm13164948 -
Atrial fibrillation after cardiac surgery: identifying candidate predictors through a Delphi process.
Bedford J, Fields KG, Collins GS, Lip GYH, et al · · 2024 · cited 2× · PMID 39322590 · DOI 10.1136/bmjopen-2024-086589
Verify or expand the search:
- PubMed search for NCT05255224
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Not applicable as observational study
Trials testing the same drug.
- NCT04838106 — Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales · active not recruiting
Other recruiting trials for Atrial Fibrillation New Onset
Currently open trials in the same condition.
- NCT05841056 — Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial · Phase 3 · recruiting
- NCT06275503 — STROKESTOP III - Optimized Method for Atrial Fibrillation Screening · NA · recruiting
- NCT06159985 — Effect of Left Posterior Pericardiotomy for the Prevention of POAF · NA · recruiting
- NCT05444335 — Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years · NA · active not recruiting
- NCT05229211 — Tracking Atrial Fibrillation After Intensive Care Admission · recruiting
Other University of Oxford trials
Trials by the same sponsor.
- NCT05380388 — A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 ) · Phase 2 · not yet recruiting
- NCT07470424 — A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults · Phase 1 · not yet recruiting
- NCT07345910 — Environment, Pathogens, and Host Interactions in Melioidosis · not yet recruiting
- NCT07434973 — Stratification and Treatment in Early Psychosis Study - PROMOTE · Phase 3 · not yet recruiting
- NCT07460401 — 'Do Patient Characteristics Associate With Poor Outcome With Femoral Acetabular Impingement Syndrome (FAIS) Following Ph · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05255224 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oxford
- Last refreshed: 23 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05255224.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing